Current Pharmaceutical Biotechnology
Title:Preface: Studies on Understanding and Anti-Tumor Agents of Reproductive Cancer Cells
Volume: 18 Issue: 1
Author(s): Cheorl-Ho Kim
Affiliation:
Keywords: Breast cancer, prostate cancer, leiomyoma, gangliosides, steroid receptors, chemoprevention, anti-tumor activity, cell signaling.
Export Options
About this article
Cite this article as:
Kim Cheorl-Ho, Preface: Studies on Understanding and Anti-Tumor Agents of Reproductive Cancer Cells, Current Pharmaceutical Biotechnology 2017; 18 (1) . https://dx.doi.org/10.2174/138920101801170113222330
DOI https://dx.doi.org/10.2174/138920101801170113222330 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology
Current Pharmaceutical Design Convection-Enhanced Delivery: Neurosurgical Issues
Current Drug Targets Chemical Synthesis, Characterisation and Biological Evaluation of Furanic- Estradiol Derivatives as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
Medicinal Chemistry Hydroxytyrosol and Derivatives: Isolation, Synthesis, and Biological Properties
Current Organic Chemistry Isothiocyanates in the Chemoprevention of Bladder Cancer
Current Drug Metabolism Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Current Signal Transduction Therapy Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas
Current Cancer Drug Targets Antiinflammatory Activity of Melatonin in Central Nervous System
Current Neuropharmacology Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases
Anti-Cancer Agents in Medicinal Chemistry Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Current Proteomics Recent Clinical Experience with Oncolytic Viruses
Current Pharmaceutical Biotechnology Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases
Current Pharmaceutical Design Pharmacoepigenomics: An Interplay of Epigenetic Modulation of Drug Response and Modulation of the Epigenome by Drugs
Current Pharmaceutical Design PET Imaging with [<sup>68</sup>Ga]NOTA-RGD for Prostate Cancer: A Comparative Study with [<sup>18</sup>F]Fluorodeoxyglucose and [<sup>18</sup>F]Fluoroethylcholine
Current Cancer Drug Targets Inflammation in Neurodegenerative Disorders: Friend or Foe?
Current Aging Science Glucose Transporters in Sex Steroid Hormone Related Cancer
Current Vascular Pharmacology Functional Domains of Aquaporin-1: Keys to Physiology, and Targets for Drug Discovery
Current Pharmaceutical Design Resveratrol in Cancer: Cellular and Mitochondrial Consequences of Proton Transport Inhibition
Current Pharmaceutical Design The Antidepressant-like Effects of Estrogen-mediated Ghrelin
Current Neuropharmacology Properties and Therapeutic Potential of Transient Receptor Potential Channels with Putative Roles in Adversity: Focus on TRPC5, TRPM2 and TRPA1
Current Drug Targets